119th Congress
S. 4987
Pharmaceutical Investment Oversight and Accountability Act
- Introduced
- In committee
- Passed Senate
- Passed House
- To President
- Became law
- Sponsor
- Elizabeth Warren(D-MA)
- Introduced
- Jul 15, 2026
- Policy area
- Health
- Committees
- Senate Committee on Banking, Housing, and Urban Affairs
- Official text
- Introduced in Senate · Congress.gov page
Cosponsors (2)
Original cosponsors (2)
- Kirsten E. Gillibrand (D-NY)
- Rick Scott (R-FL)
Summary
No Congressional Research Service summary yet. CRS usually publishes one a few weeks after a bill is introduced.
Official title: A bill to require the Federal Trade Commission to submit a report on foreign investment in the pharmaceutical industry of the United States, and for other purposes.
Latest action(Jul 15, 2026): Read twice and referred to the Committee on Banking, Housing, and Urban Affairs.
Roll-call votes
No recorded votes on this bill.
Actions
- Jul 15, 2026 · Senate
Read twice and referred to the Committee on Banking, Housing, and Urban Affairs. - Jul 15, 2026
Introduced in Senate